Tip60 inhibitor treatment significantly reduced K8, RTA, and ORF26 mRNA levels in TPA/SB-stimulated BC-3 cells (Supplementary Figures S3A–C), although the effects were not as strong as those observed in the BCBL-1 cells (Figure 3). The gene discussed is KAT5; the disease is breast cancer.